Loading
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 15 Dec 2022 for Corvus Pharmaceuticals, Inc., €21k. Read the official filing
Filing timeline
BuySaleLeiv Lea
Insider track record
Disclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Leiv Lea: trading record in brief
All filings by Leiv Lea on record concern Corvus Pharmaceuticals, Inc., in the capacity of finance chief. Over a trading history stretching from 16 March 2022 to 13 December 2022, the count stands at 2 filings.
On the market, this insider has only ever bought: 2 purchases, €70k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
On 15 December 2022 came the latest disclosure, an open-market purchase for €21k in Corvus Pharmaceuticals, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Leiv Lea
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
2 of 2 declarations
